Consultant Surgeon at The Royal Marsden Hospital, London and holder of a Personal Chair in Surgical Oncology at Imperial College London
Melanoma is one of the most often reported and lethal donor derived malignancies but nature’s own unfortunate experiment may hold the answer to mysterious behaviour in the sentinel node.
The 7th World Melanoma Congress will take place in Vienna, Austria between May 12th-16th 2009. This annual conference sees the movers and shakers of the world melanoma community unite to debate hot research topics. Speakers from all faculties will attend, ranging from basic science to cutting edge clinical treatment. Professor Meirion Thomas will be talking [...]
Staistical errors continue to hamper progress in the MSLT-1 trial looking at the potential role of sentinel node biopsy in the treatment of malignant melanoma.
Regular ultrasound surveillance of lymph nodes is an alternative to sentinel node biopsy. It offers an effective non-invasive method of monitoring disease activity. We explore reasons to use this modality.
Nature Clinical Practice Oncology (2008) 5, 18-23
Principles and Practice of Oncology 2008 Update
A massive 96% of patients undergo unnecessary and excessive surgery for this condition. From May 5th 2008 NHS Library on cancer explores the evidence basis for this treatment.
When melanoma spreads, it does so invariably by the lymphatic system which drains to the regional lymph nodes. Uncommonly, melanoma can become trapped in the lymphatic vessels and grow to cause tumour nodules in the skin called in-transit disease which has its own highly specialised treament methods and outcomes.
Sentinel Node Biopsy has been accepted into everyday Melanoma practice, but we explore the evidence base for this procedure, exposing why it may not offer the advantages sometimes promised by clinicians.
Wide excision and excision are biopsies explained